Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5167/uzh-238213
Publication URI: https://www.zora.uzh.ch/handle/20.500.14742/211011
Type: Journal Article/Review